The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Sponsor: University of Texas Southwestern Medical Center
This PHASE2 trial investigates Hypertension and is currently completed. University of Texas Southwestern Medical Center leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Apr 2022 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 9 earlier versions
-
Mar 2022 — Apr 2022 [monthly]
Completed PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Completed PHASE2
Status: Recruiting → Completed · Phase: NA → PHASE2
-
Apr 2021 — Feb 2022 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2019 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .